Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion

被引:245
作者
Abe, M
Hiura, K
Wilde, J
Shioyasono, A
Moriyama, K
Hashimoto, T
Kido, S
Oshima, T
Shibata, H
Ozaki, S
Inoue, D
Matsumoto, T
机构
[1] Univ Tokushima, Dept Med & Bioregulatory Sci, Grad Sch Med, Tokushima 7708503, Japan
[2] Univ Tokushima, Sch Dent, Dept Orthodont, Tokushima 7708503, Japan
[3] Univ Tokushima Hosp, Div Transfus Med, Tokushima 7708503, Japan
关键词
D O I
10.1182/blood-2003-11-3839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple myeloma (MM) expands in the bone marrow and causes devastating bone destruction by enhancing osteoclastic bone resorption in its vicinity, suggesting a close interaction between MM cells and osteoclasts (OCs). Here, we show that peripheral blood mononuclear cell-derived OCs enhanced growth and survival of primary MM cells as well as MM cell lines more potently than stromal cells, and that OCs protected MM cells from apoptosis induced by serum depletion or doxorubicin. OCs produced osteopontin (OPN) and interleukin 6 (IL-6), and adhesion of MM cells to OCs increased IL-6 production from OCs. In addition, IL-6 and OPN in combination enhanced MM cell growth and survival. However, the effects of OCs on MM cell growth and survival were only partially suppressed by a simultaneous addition of anti-IL-6 and anti-OPN antibodies and were completely abrogated by inhibition of cellular contact between MM cells and OCs. These results demonstrate that OCs enhance MM cell growth and survival through a cell-cell contact-mediated mechanism that is partially dependent on IL-6 and OPN. It is suggested that interactions of MM cells with OCs augment MM growth and survival and, thereby, form a vicious cycle, leading to extensive bone destruction and MM cell expansion. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2484 / 2491
页数:8
相关论文
共 52 条
  • [31] RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
    Nakagawa, N
    Kinosaki, M
    Yamaguchi, K
    Shima, N
    Yasuda, H
    Yano, K
    Morinaga, T
    Higashio, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (02) : 395 - 400
  • [32] Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues
    Nemoto, H
    Rittling, SR
    Yoshitake, H
    Furuya, K
    Amagasa, T
    Tsuji, K
    Nifuji, A
    Denhardt, DT
    Noda, M
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (04) : 652 - 659
  • [33] Dual effects of macrophage inflammatory protein-1α on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease
    Oyajobi, BO
    Franchin, G
    Williams, PJ
    Pulkrabek, D
    Gupta, A
    Munoz, S
    Grubbs, B
    Zhao, M
    Chen, D
    Sherry, B
    Mundy, GR
    [J]. BLOOD, 2003, 102 (01) : 311 - 319
  • [34] Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells
    Ozaki, S
    Kosaka, M
    Wakahara, Y
    Ozaki, Y
    Tsuchiya, M
    Koishihara, Y
    Goto, T
    Matsumoto, T
    [J]. BLOOD, 1999, 93 (11) : 3922 - 3930
  • [35] Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression
    Pearse, RN
    Sordillo, EM
    Yaccoby, S
    Wong, BR
    Liau, DF
    Colman, N
    Michaeli, J
    Epstein, J
    Choi, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) : 11581 - 11586
  • [36] A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
    Quinn, JMW
    Elliott, J
    Gillespie, MT
    Martin, TJ
    [J]. ENDOCRINOLOGY, 1998, 139 (10) : 4424 - 4427
  • [37] INDUCIBLE CELL-ADHESION MOLECULE-110 (INCAM-110) IS AN ENDOTHELIAL RECEPTOR FOR LYMPHOCYTES - A CD11 CD18-INDEPENDENT ADHESION MECHANISM
    RICE, GE
    MUNRO, JM
    BEVILACQUA, MP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (04) : 1369 - 1374
  • [38] Role of the bone marrow microenvironment in multiple myeloma
    Roodman, GD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (11) : 1921 - 1925
  • [39] Sabokbar A, 2003, METH MOLEC MED, V80, P101
  • [40] RANK ligand and osteoprotegerin in myeloma bone disease
    Sezer, O
    Heider, U
    Zavrski, I
    Kühne, CA
    Hofbauer, LC
    [J]. BLOOD, 2003, 101 (06) : 2094 - 2098